Viquidacin

DB19549ExperimentalSmall molecule

Viquidacin is a small molecule drug. The usage of the INN stem '-dacin' in the name indicates that Viquidacin is a antibiotic, DNA gyrase and topoisomerase IV inhibitor. Viquidacin has... Viquidacin has a monoisotopic molecular weight of 504.16 Da.

Formula / weight: C₂₅H₂₉FN₂O₄S₂ · 504.64 g/mol (avg)
Code names: NXL-101

Resolves to

Compound

UNII0TA0YE45QECAS904302-98-3ChEMBLCHEMBL2158050

Structure

InChIKeyUSGHRRVFKSLEJT-WVBUVRCRSA-NSMILESCOC1=CC2=C([C@@H](O)CC[C@@H]3CCN(CCSC4=CC=CS4)C[C@@H]3C(O)=O)C(F)=CN=C2C=C1

Targets

P20831gyrAP0A0K8gyrB

What you can answer from here — as of August 29, 2026

2Protein targetsEach mapped to UniProt, with action and pharmacological action

Listed above

2+ReferencesStructured and connected to the statements they support

Which drugs share a target with Viquidacin, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account